Market Cap
High in industry
PE TTM
Negative PE TTM
PEG TTM
PEG TTM is negative
Price to Book
High in industry
Beta 1Year
Very Low volatility
Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|
Christensen James | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 57.50 per share. | 18 Dec 2023 | 2,387 | 141,645 (0%) | 0% | 57.5 | 137,253 | Common Stock |
Hickey Benjamin J. | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 56.67 per share. | 13 Dec 2023 | 2,220 | 103,694 (0%) | 0% | 56.7 | 125,807 | Common Stock |
Faheem Hasnain | Director | Purchase of securities on an exchange or from another person at price $ 27.80 per share. | 11 Aug 2023 | 10,791 | 10,791 (0%) | 0% | 27.8 | 299,990 | Common Stock |
Charles M. Baum | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 37.00 per share. | 09 Aug 2023 | 54,054 | 227,275 (0%) | 0% | 37 | 1,999,998 | Common Stock |
James Christensen | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 37.00 per share. | 09 Aug 2023 | 22,297 | 146,420 (0%) | 0% | 37 | 824,989 | Common Stock |
Laurie D. Stelzer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 37.00 per share. | 09 Aug 2023 | 22,297 | 102,312 (0%) | 0% | 37 | 824,989 | Common Stock |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 37.00 per share. | 09 Aug 2023 | 22,297 | 105,914 (0%) | 0% | 37 | 824,989 | Common Stock |
Alan B. Sandler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 37.00 per share. | 09 Aug 2023 | 22,297 | 62,297 (0%) | 0% | 37 | 824,989 | Common Stock |
Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 12,784 | 12,784 | - | - | Employee Stock Option (Right to Buy) | |
Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 7,555 | 7,555 (0%) | 0% | 0 | Common Stock | |
Laurie D. Stelzer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 37.06 per share. | 02 Jun 2023 | 4,647 | 80,015 (0%) | 0% | 37.1 | 172,218 | Common Stock |
James Christensen | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 45.29 per share. | 24 May 2023 | 619 | 124,123 (0%) | 0% | 45.3 | 28,035 | Common Stock |
Bruce L.A. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,444 | 10,465 (0%) | 0% | 0 | Common Stock | |
Bruce L.A. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 7,520 | 7,520 | - | - | Non Qualified Stock Option (right to buy) | |
Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 6,333 | 15,050 (0%) | 0% | 0 | Common Stock | |
Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 10,716 | 10,716 | - | - | Non Qualified Stock Option (right to buy) | |
Henry J. Fuchs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 7,520 | 7,520 | - | - | Non Qualified Stock Option (right to buy) | |
Henry J. Fuchs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,444 | 10,465 (0%) | 0% | 0 | Common Stock | |
Shalini Sharp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 7,520 | 7,520 | - | - | Non Qualified Stock Option (right to buy) | |
Shalini Sharp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,444 | 9,414 (0%) | 0% | 0 | Common Stock | |
Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,444 | 10,465 (0%) | 0% | 0 | Common Stock | |
Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 7,520 | 7,520 | - | - | Non Qualified Stock Option (right to buy) | |
Julie M. Cherrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 7,520 | 7,520 | - | - | Non Qualified Stock Option (right to buy) | |
Julie M. Cherrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,444 | 4,444 (0%) | 0% | 0 | Common Stock | |
David D. Meek | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 151,233 | 151,233 | - | - | Employee Stock Option (Right to Buy) | |
David D. Meek | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 89,379 | 151,171 (0%) | 0% | 0 | Common Stock | |
Charles M. Baum | Director, President,Founder,Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,444 | 173,221 (0%) | 0% | 0 | Common Stock | |
Charles M. Baum | Director, President,Founder,Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 7,520 | 7,520 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 26,864 | 124,742 (0%) | 0% | 0 | Common Stock | |
James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 45,456 | 45,456 | - | - | Employee Stock Option (Right to Buy) | |
Laurie D. Stelzer | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 45,456 | 45,456 | - | - | Employee Stock Option (Right to Buy) | |
Laurie D. Stelzer | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 26,864 | 84,662 (0%) | 0% | 0 | Common Stock | |
Aaron I. Davis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 7,520 | 7,520 | - | - | Non Qualified Stock Option (right to buy) | |
Aaron I. Davis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,444 | 47,517 (0%) | 0% | 0 | Common Stock | |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 36,394 | 83,617 (0%) | 0% | 0 | Common Stock | |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 45,456 | 45,456 | - | - | Employee Stock Option (Right to Buy) | |
Maria E Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 7,520 | 7,520 | - | - | Non Qualified Stock Option (right to buy) | |
Maria E Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,444 | 10,465 (0%) | 0% | 0 | Common Stock | |
Julie M. Cherrington | Director | Sale of securities on an exchange or to another person at price $ 44.66 per share. | 18 Jan 2023 | 2,546 | 0 (0%) | 0% | 44.7 | 113,704 | Common Stock |
David D. Meek | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 42.38 per share. | 17 Jan 2023 | 3,179 | 61,792 (0%) | 0% | 42.4 | 134,715 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 42.38 per share. | 17 Jan 2023 | 887 | 97,878 (0%) | 0% | 42.4 | 37,593 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 42.38 per share. | 17 Jan 2023 | 1,358 | 98,765 (0%) | 0% | 42.4 | 57,549 | Common Stock |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 42.38 per share. | 17 Jan 2023 | 947 | 47,842 (0%) | 0% | 42.4 | 40,132 | Common Stock |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 42.38 per share. | 17 Jan 2023 | 619 | 47,223 (0%) | 0% | 42.4 | 26,234 | Common Stock |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 45.37 per share. | 09 Jan 2023 | 2,088 | 48,789 (0%) | 0% | 45.4 | 94,733 | Common Stock |
Charles M. Baum | Director, President,Founder,Head of R&D | Sale of securities on an exchange or to another person at price $ 46.60 per share. | 04 Jan 2023 | 3,648 | 168,777 (0%) | 0% | 46.6 | 169,997 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 46.60 per share. | 04 Jan 2023 | 1,949 | 100,123 (0%) | 0% | 46.6 | 90,823 | Common Stock |
David D. Meek | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2022 | 35,425 | 69,587 (0%) | 0% | 0 | Common Stock | |
David D. Meek | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.41 per share. | 19 Dec 2022 | 4,616 | 64,971 (0%) | 0% | 40.4 | 186,552 | Common Stock |
Charles M. Baum | Director, President,Founder,Head of R&D | Sale of securities on an exchange or to another person at price $ 40.42 per share. | 19 Dec 2022 | 9,092 | 172,425 (0%) | 0% | 40.4 | 367,469 | Common Stock |
Charles M. Baum | Director, President,Founder,Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2022 | 53,618 | 181,517 (0%) | 0% | 0 | Common Stock | |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 40.41 per share. | 19 Dec 2022 | 3,248 | 50,877 (0%) | 0% | 40.4 | 131,266 | Common Stock |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2022 | 19,149 | 54,125 (0%) | 0% | 0 | Common Stock | |
James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 43.00 per share. | 16 Dec 2022 | 2,410 | 102,072 (0%) | 0% | 43.0 | 103,624 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 90.19 per share. | 02 Dec 2022 | 1,726 | 104,482 (0%) | 0% | 90.2 | 155,667 | Common Stock |
Charles M. Baum | Director, President,Founder,Head of R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2022 | 69,256 | 69,258 | - | - | Employee Stock Option (Right to Buy) | |
Charles M. Baum | Director, President,Founder,Head of R&D | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 28 Nov 2022 | 69,256 | 127,899 (0%) | 0% | 100 | 6,925,600 | Common Stock |
Charles M. Baum | Director, President,Founder,Head of R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.41 per share. | 28 Nov 2022 | 69,256 | 197,155 (0%) | 0% | 17.4 | 1,205,747 | Common Stock |
Alan B. Sandler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to buy) | |
Alan B. Sandler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 40,000 | 40,000 (0%) | 0% | 0 | Common Stock | |
James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2022 | 19,149 | 106,089 (0%) | 0% | 0 | Common Stock | |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 85.96 per share. | 12 Aug 2022 | 4,893 | 6,021 (0%) | 0% | 86.0 | 420,612 | Common Stock |
Bruce L.A. Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2022 | 10,000 | 0 | - | - | Non Qualified Stock Option (right to buy) | |
Bruce L.A. Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.00 per share. | 12 Aug 2022 | 10,000 | 16,021 (0%) | 0% | 27 | 270,000 | Common Stock |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 85.04 per share. | 12 Aug 2022 | 5,107 | 10,914 (0%) | 0% | 85.0 | 434,287 | Common Stock |
Laurie D. Stelzer | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 91,164 | 91,164 | - | - | Employee Stock Option (Right to Buy) | |
Laurie D. Stelzer | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 57,798 | 57,798 (0%) | 0% | 0 | Common Stock | |
James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 63.54 per share. | 23 May 2022 | 624 | 86,804 (0%) | 0% | 63.5 | 39,649 | Common Stock |
Henry J. Fuchs | Director | Sale of securities on an exchange or to another person at price $ 104.76 per share. | 11 Feb 2022 | 2,090 | 14,931 (0%) | 0% | 104.8 | 218,958 | Common Stock |
Henry J. Fuchs | Director | Sale of securities on an exchange or to another person at price $ 106.34 per share. | 11 Feb 2022 | 210 | 6,021 (0%) | 0% | 106.3 | 22,332 | Common Stock |
Henry J. Fuchs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 5,000 | 0 | - | - | Non Qualified Stock Option (right to buy) | |
Henry J. Fuchs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 6,000 | 0 | - | - | Non Qualified Stock Option (right to buy) | |
Henry J. Fuchs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.54 per share. | 11 Feb 2022 | 6,000 | 12,021 (0%) | 0% | 20.5 | 123,240 | Common Stock |
Henry J. Fuchs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.54 per share. | 11 Feb 2022 | 5,000 | 17,021 (0%) | 0% | 20.5 | 102,700 | Common Stock |
Henry J. Fuchs | Director | Sale of securities on an exchange or to another person at price $ 105.80 per share. | 11 Feb 2022 | 8,700 | 6,231 (0%) | 0% | 105.8 | 920,428 | Common Stock |
Julie M. Cherrington | Director | Sale of securities on an exchange or to another person at price $ 116.07 per share. | 19 Jan 2022 | 1,475 | 2,546 (0%) | 0% | 116.1 | 171,203 | Common Stock |
Bruce L.A. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 2,546 | 6,021 (0%) | 0% | 0 | Common Stock | |
Bruce L.A. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 3,688 | 3,688 | - | - | Non Qualified Stock Option (right to buy) | |
Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 3,619 | 8,717 (0%) | 0% | 0 | Common Stock | |
Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 5,243 | 5,243 | - | - | Non Qualified Stock Option (right to buy) | |
Henry J. Fuchs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 3,688 | 3,688 | - | - | Non Qualified Stock Option (right to buy) | |
Henry J. Fuchs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 2,546 | 6,021 (0%) | 0% | 0 | Common Stock | |
Shalini Sharp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 3,688 | 3,688 | - | - | Non Qualified Stock Option (right to buy) | |
Shalini Sharp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 2,546 | 4,970 (0%) | 0% | 0 | Common Stock | |
Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 3,688 | 3,688 | - | - | Non Qualified Stock Option (right to buy) | |
Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 2,546 | 6,021 (0%) | 0% | 0 | Common Stock | |
Julie M. Cherrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 2,546 | 4,021 (0%) | 0% | 0 | Common Stock | |
Julie M. Cherrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 3,688 | 3,688 | - | - | Non Qualified Stock Option (right to buy) | |
David D. Meek | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 34,057 | 34,057 (0%) | 0% | 0 | Common Stock | |
David D. Meek | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 56,433 | 56,433 | - | - | Employee Stock Option (Right to Buy) | |
Charles M. Baum | Director, President,Founder,Head of R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 3,703 | 178,052 | - | - | Employee Stock Option (Right to Buy) | |
Charles M. Baum | Director, President,Founder,Head of R&D | Sale of securities on an exchange or to another person at price $ 120.48 per share. | 14 Jan 2022 | 2,517 | 127,899 (0%) | 0% | 120.5 | 303,253 | Common Stock |
Charles M. Baum | Director, President,Founder,Head of R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.00 per share. | 14 Jan 2022 | 3,703 | 130,416 (0%) | 0% | 27 | 99,981 | Common Stock |
Charles M. Baum | Director, President,Founder,Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 25,543 | 126,713 (0%) | 0% | 0 | Common Stock | |
Charles M. Baum | Director, President,Founder,Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 42,325 | 42,325 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 17,821 | 17,821 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 120.51 per share. | 14 Jan 2022 | 627 | 87,428 (0%) | 0% | 120.5 | 75,558 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 10,755 | 88,055 (0%) | 0% | 0 | Common Stock | |
Aaron I. Davis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 3,688 | 3,688 | - | - | Non Qualified Stock Option (right to buy) | |
Aaron I. Davis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 2,546 | 43,073 (0%) | 0% | 0 | Common Stock | |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 120.48 per share. | 14 Jan 2022 | 627 | 34,976 (0%) | 0% | 120.5 | 75,543 | Common Stock |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 10,755 | 35,603 (0%) | 0% | 0 | Common Stock | |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 17,821 | 17,821 | - | - | Employee Stock Option (Right to Buy) | |
Maria E Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 2,546 | 6,021 (0%) | 0% | 0 | Common Stock | |
Maria E Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 3,688 | 3,688 | - | - | Non Qualified Stock Option (right to buy) | |
Vickie S. Reed | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 8,910 | 8,910 | - | - | Employee Stock Option (Right to Buy) | |
Vickie S. Reed | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 5,377 | 15,902 (0%) | 0% | 0 | Common Stock | |
Vickie S. Reed | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 120.48 per share. | 14 Jan 2022 | 533 | 15,369 (0%) | 0% | 120.5 | 64,217 | Common Stock |
Charles M. Baum | Director, President,Founder,Head of R&D | Sale of securities on an exchange or to another person at price $ 149.09 per share. | 04 Jan 2022 | 69 | 101,170 (0%) | 0% | 149.1 | 10,287 | Common Stock |
Charles M. Baum | Director, President,Founder,Head of R&D | Sale of securities on an exchange or to another person at price $ 147.73 per share. | 04 Jan 2022 | 4,045 | 101,239 (0%) | 0% | 147.7 | 597,568 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 147.72 per share. | 04 Jan 2022 | 1,442 | 77,300 (0%) | 0% | 147.7 | 213,017 | Common Stock |
Vickie S. Reed | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 147.74 per share. | 04 Jan 2022 | 758 | 10,870 (0%) | 0% | 147.7 | 111,987 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 154.34 per share. | 24 May 2021 | 435 | 53,850 (0%) | 0% | 154.3 | 67,138 | Common Stock |
Bruce L.A. Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.78 per share. | 05 Apr 2021 | 2,250 | 5,725 (0%) | 0% | 6.8 | 15,255 | Common Stock |
Bruce L.A. Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 2,250 | 0 | - | - | Non Qualified Stock Option (right to buy) | |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 180.00 per share. | 05 Apr 2021 | 282 | 3,475 (0%) | 0% | 180 | 50,760 | Common Stock |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 176.70 per share. | 05 Apr 2021 | 1,968 | 3,757 (0%) | 0% | 176.7 | 347,747 | Common Stock |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 175.54 per share. | 19 Mar 2021 | 588 | 28,593 (0%) | 0% | 175.5 | 103,216 | Common Stock |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2021 | 2,369 | 30,116 | - | - | Non Qualified Stock Option (right to buy) | |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 177.71 per share. | 19 Mar 2021 | 431 | 26,812 (0%) | 0% | 177.7 | 76,591 | Common Stock |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 176.42 per share. | 19 Mar 2021 | 1,350 | 27,243 (0%) | 0% | 176.4 | 238,171 | Common Stock |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 114.33 per share. | 19 Mar 2021 | 2,369 | 29,181 (0%) | 0% | 114.3 | 270,848 | Common Stock |
Julie M. Cherrington | Director | Sale of securities on an exchange or to another person at price $ 203.00 per share. | 02 Mar 2021 | 10 | 1,475 (0%) | 0% | 203 | 2,030 | Common Stock |
Julie M. Cherrington | Director | Sale of securities on an exchange or to another person at price $ 201.00 per share. | 02 Mar 2021 | 1,990 | 1,485 (0%) | 0% | 201 | 399,990 | Common Stock |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 190.50 per share. | 02 Feb 2021 | 1,732 | 3,993 (0%) | 0% | 190.5 | 329,948 | Common Stock |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 194.38 per share. | 02 Feb 2021 | 218 | 3,475 (0%) | 0% | 194.4 | 42,375 | Common Stock |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 02 Feb 2021 | 300 | 3,693 (0%) | 0% | 192.3 | 57,695 | Common Stock |
Bruce L.A. Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.78 per share. | 02 Feb 2021 | 2,250 | 5,725 (0%) | 0% | 6.8 | 15,255 | Common Stock |
Bruce L.A. Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2021 | 2,250 | 2,250 | - | - | Non Qualified Stock Option (right to buy) | |
Daniel R. Faga | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2021 | 1,340 | 63,630 | - | - | Non Qualified Stock Option (right to buy) | |
Daniel R. Faga | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 194.38 per share. | 02 Feb 2021 | 1,340 | 30,638 (0%) | 0% | 194.4 | 260,469 | Common Stock |
Daniel R. Faga | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 114.33 per share. | 02 Feb 2021 | 1,340 | 31,978 (0%) | 0% | 114.3 | 153,202 | Common Stock |
Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 197.14 per share. | 29 Jan 2021 | 50 | 10,925 (0%) | 0% | 197.1 | 9,857 | Common Stock |
Maria E Martinez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2021 | 7,500 | 17,500 | - | - | Non Qualified Stock Option (right to buy) | |
Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 207.82 per share. | 29 Jan 2021 | 200 | 3,475 (0%) | 0% | 207.8 | 41,565 | Common Stock |
Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 206.63 per share. | 29 Jan 2021 | 1,100 | 3,675 (0%) | 0% | 206.6 | 227,297 | Common Stock |
Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 205.26 per share. | 29 Jan 2021 | 975 | 4,775 (0%) | 0% | 205.3 | 200,125 | Common Stock |
Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 204.43 per share. | 29 Jan 2021 | 1,205 | 5,750 (0%) | 0% | 204.4 | 246,333 | Common Stock |
Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 203.43 per share. | 29 Jan 2021 | 1,579 | 6,955 (0%) | 0% | 203.4 | 321,219 | Common Stock |
Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 201.99 per share. | 29 Jan 2021 | 960 | 8,534 (0%) | 0% | 202.0 | 193,911 | Common Stock |
Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 200.90 per share. | 29 Jan 2021 | 462 | 9,494 (0%) | 0% | 200.9 | 92,818 | Common Stock |
Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 200.05 per share. | 29 Jan 2021 | 719 | 9,956 (0%) | 0% | 200.1 | 143,839 | Common Stock |
Maria E Martinez | Director | Sale of securities on an exchange or to another person at price $ 198.48 per share. | 29 Jan 2021 | 250 | 10,675 (0%) | 0% | 198.5 | 49,621 | Common Stock |
Maria E Martinez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.76 per share. | 29 Jan 2021 | 7,500 | 10,975 (0%) | 0% | 39.8 | 298,200 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2021 | 2,292 | 100,273 | - | - | Employee Stock Option (Right to Buy) | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 26 Jan 2021 | 2,292 | 112,714 (0%) | 0% | 5.4 | 12,377 | Common Stock |
Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 210.01 per share. | 21 Jan 2021 | 3,505 | 14,970 (0%) | 0% | 210.0 | 736,070 | Common Stock |
Craig A. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.54 per share. | 21 Jan 2021 | 15,000 | 18,475 (0%) | 0% | 20.5 | 308,100 | Common Stock |
Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 210.81 per share. | 21 Jan 2021 | 3,183 | 11,787 (0%) | 0% | 210.8 | 671,004 | Common Stock |
Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 211.94 per share. | 21 Jan 2021 | 4,562 | 7,225 (0%) | 0% | 211.9 | 966,852 | Common Stock |
Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 212.97 per share. | 21 Jan 2021 | 3,372 | 3,853 (0%) | 0% | 213.0 | 718,151 | Common Stock |
Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 213.61 per share. | 21 Jan 2021 | 44 | 3,809 (0%) | 0% | 213.6 | 9,399 | Common Stock |
Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 214.75 per share. | 21 Jan 2021 | 334 | 3,475 (0%) | 0% | 214.8 | 71,728 | Common Stock |
Craig A. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2021 | 15,000 | 0 | - | - | Non Qualified Stock Option (right to buy) | |
Bruce L.A. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 2,155 | 2,155 | - | - | Non Qualified Stock Option (right to buy) | |
Bruce L.A. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 1,475 | 3,475 (0%) | 0% | 0 | Common Stock | |
Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 2,098 | 5,098 (0%) | 0% | 0 | Common Stock | |
Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 3,064 | 3,064 | - | - | Non Qualified Stock Option (right to buy) | |
Henry J. Fuchs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 1,475 | 3,475 (0%) | 0% | 0 | Common Stock | |
Henry J. Fuchs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 2,155 | 2,155 | - | - | Non Qualified Stock Option (right to buy) | |
Michael G. Grey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 2,155 | 2,155 | - | - | Non Qualified Stock Option (right to buy) | |
Michael G. Grey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 1,475 | 5,731 (0%) | 0% | 0 | Common Stock | |
Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 1,475 | 3,475 (0%) | 0% | 0 | Common Stock | |
Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 2,155 | 2,155 | - | - | Non Qualified Stock Option (right to buy) | |
Julie M. Cherrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 2,155 | 2,155 | - | - | Non Qualified Stock Option (right to buy) | |
Julie M. Cherrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 1,475 | 3,475 (0%) | 0% | 0 | Common Stock | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 3,245 | 181,755 | - | - | Employee Stock Option (Right to Buy) | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.00 per share. | 15 Jan 2021 | 3,245 | 110,422 (0%) | 0% | 27 | 87,615 | Common Stock |
Charles M. Baum | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 19,665 | 107,177 (0%) | 0% | 0 | Common Stock | |
Charles M. Baum | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 30,742 | 30,742 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 7,023 | 54,285 (0%) | 0% | 0 | Common Stock | |
James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 10,979 | 10,979 | - | - | Employee Stock Option (Right to Buy) | |
Daniel R. Faga | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 7,023 | 30,638 (0%) | 0% | 0 | Common Stock | |
Daniel R. Faga | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 10,979 | 10,979 | - | - | Employee Stock Option (Right to Buy) | |
Aaron I. Davis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 1,475 | 40,527 (0%) | 0% | 0 | Common Stock | |
Aaron I. Davis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 2,155 | 2,155 | - | - | Non Qualified Stock Option (right to buy) | |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 7,023 | 26,812 (0%) | 0% | 0 | Common Stock | |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 10,979 | 10,979 | - | - | Employee Stock Option (Right to Buy) | |
Maria E Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 1,475 | 3,475 (0%) | 0% | 0 | Common Stock | |
Maria E Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 2,155 | 2,155 | - | - | Non Qualified Stock Option (right to buy) | |
Vickie Reed | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 6,499 | 6,499 | - | - | Employee Stock Option (Right to Buy) | |
Vickie Reed | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 4,157 | 11,628 (0%) | 0% | 0 | Common Stock | |
Daniel R. Faga | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 215.33 per share. | 07 Jan 2021 | 12 | 26,228 (0%) | 0% | 215.3 | 2,584 | Common Stock |
Daniel R. Faga | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 216.33 per share. | 07 Jan 2021 | 2,613 | 23,615 (0%) | 0% | 216.3 | 565,270 | Common Stock |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 215.33 per share. | 07 Jan 2021 | 9 | 21,858 (0%) | 0% | 215.3 | 1,938 | Common Stock |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 216.33 per share. | 07 Jan 2021 | 2,069 | 19,789 (0%) | 0% | 216.3 | 447,587 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 210.28 per share. | 06 Jan 2021 | 4,421 | 87,512 (0%) | 0% | 210.3 | 929,648 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 215.76 per share. | 06 Jan 2021 | 90 | 91,933 (0%) | 0% | 215.8 | 19,418 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 215.86 per share. | 06 Jan 2021 | 29 | 48,692 (0%) | 0% | 215.9 | 6,260 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 210.28 per share. | 06 Jan 2021 | 1,430 | 47,262 (0%) | 0% | 210.3 | 300,700 | Common Stock |
Vickie Reed | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 215.73 per share. | 06 Jan 2021 | 11 | 8,239 (0%) | 0% | 215.7 | 2,373 | Common Stock |
Vickie Reed | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 216.33 per share. | 06 Jan 2021 | 241 | 7,471 (0%) | 0% | 216.3 | 52,135 | Common Stock |
Vickie Reed | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 210.28 per share. | 06 Jan 2021 | 527 | 7,712 (0%) | 0% | 210.3 | 110,818 | Common Stock |
Charles M. Baum | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Dec 2020 | 10,000 | 92,023 (0%) | 0% | 0 | Common Stock | |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 233.43 per share. | 18 Dec 2020 | 9,888 | 132,135 (0%) | 0% | 233.4 | 2,308,145 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.49 per share. | 18 Dec 2020 | 40,000 | 142,023 (0%) | 0% | 8.5 | 339,600 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 234.26 per share. | 18 Dec 2020 | 22,932 | 109,203 (0%) | 0% | 234.3 | 5,371,998 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2020 | 40,000 | 87,204 | - | - | Employee Stock Option (Right to Buy) | |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 240.23 per share. | 18 Dec 2020 | 317 | 102,023 (0%) | 0% | 240.2 | 76,153 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 238.76 per share. | 18 Dec 2020 | 100 | 102,340 (0%) | 0% | 238.8 | 23,876 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 237.25 per share. | 18 Dec 2020 | 2,020 | 102,440 (0%) | 0% | 237.3 | 479,255 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 236.17 per share. | 18 Dec 2020 | 4,250 | 104,460 (0%) | 0% | 236.2 | 1,003,732 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 235.20 per share. | 18 Dec 2020 | 493 | 108,710 (0%) | 0% | 235.2 | 115,956 | Common Stock |
Henry J. Fuchs | Director | Sale of securities on an exchange or to another person at price $ 230.19 per share. | 15 Dec 2020 | 1,218 | 10,782 (0%) | 0% | 230.2 | 280,368 | Common Stock |
Henry J. Fuchs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 10,000 | 6,000 | - | - | Non Qualified Stock Option (right to buy) | |
Henry J. Fuchs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.54 per share. | 15 Dec 2020 | 10,000 | 12,000 (0%) | 0% | 20.5 | 205,400 | Common Stock |
Henry J. Fuchs | Director | Sale of securities on an exchange or to another person at price $ 237.90 per share. | 15 Dec 2020 | 40 | 2,000 (0%) | 0% | 237.9 | 9,516 | Common Stock |
Henry J. Fuchs | Director | Sale of securities on an exchange or to another person at price $ 237.36 per share. | 15 Dec 2020 | 451 | 2,040 (0%) | 0% | 237.4 | 107,049 | Common Stock |
Henry J. Fuchs | Director | Sale of securities on an exchange or to another person at price $ 235.19 per share. | 15 Dec 2020 | 1,821 | 2,491 (0%) | 0% | 235.2 | 428,284 | Common Stock |
Henry J. Fuchs | Director | Sale of securities on an exchange or to another person at price $ 234.27 per share. | 15 Dec 2020 | 610 | 4,312 (0%) | 0% | 234.3 | 142,907 | Common Stock |
Henry J. Fuchs | Director | Sale of securities on an exchange or to another person at price $ 233.40 per share. | 15 Dec 2020 | 4,461 | 4,922 (0%) | 0% | 233.4 | 1,041,207 | Common Stock |
Henry J. Fuchs | Director | Sale of securities on an exchange or to another person at price $ 232.01 per share. | 15 Dec 2020 | 1,399 | 9,383 (0%) | 0% | 232.0 | 324,576 | Common Stock |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 244.97 per share. | 14 Dec 2020 | 589 | 3,325 (0%) | 0% | 245.0 | 144,287 | Common Stock |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 240.94 per share. | 14 Dec 2020 | 49 | 4,201 (0%) | 0% | 240.9 | 11,806 | Common Stock |
Bruce L.A. Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.78 per share. | 14 Dec 2020 | 2,250 | 4,250 (0%) | 0% | 6.8 | 15,255 | Common Stock |
Bruce L.A. Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2020 | 2,250 | 4,500 | - | - | Non Qualified Stock Option (right to buy) | |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 249.00 per share. | 14 Dec 2020 | 1 | 2,000 (0%) | 0% | 249 | 249 | Common Stock |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 248.27 per share. | 14 Dec 2020 | 357 | 2,001 (0%) | 0% | 248.3 | 88,634 | Common Stock |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 247.63 per share. | 14 Dec 2020 | 710 | 2,358 (0%) | 0% | 247.6 | 175,817 | Common Stock |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 246.27 per share. | 14 Dec 2020 | 257 | 3,068 (0%) | 0% | 246.3 | 63,292 | Common Stock |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 244.05 per share. | 14 Dec 2020 | 287 | 3,914 (0%) | 0% | 244.0 | 70,041 | Common Stock |
Michael G. Grey | Director | Sale of securities on an exchange or to another person at price $ 245.11 per share. | 14 Dec 2020 | 1,284 | 9,168 (0%) | 0% | 245.1 | 314,725 | Common Stock |
Michael G. Grey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2020 | 10,900 | 0 | - | - | Non Qualified Stock Option (right to buy) | |
Michael G. Grey | Director | Sale of securities on an exchange or to another person at price $ 249.42 per share. | 14 Dec 2020 | 89 | 4,256 (0%) | 0% | 249.4 | 22,198 | Common Stock |
Michael G. Grey | Director | Sale of securities on an exchange or to another person at price $ 248.55 per share. | 14 Dec 2020 | 1,019 | 4,345 (0%) | 0% | 248.5 | 253,269 | Common Stock |
Michael G. Grey | Director | Sale of securities on an exchange or to another person at price $ 247.62 per share. | 14 Dec 2020 | 1,997 | 5,364 (0%) | 0% | 247.6 | 494,502 | Common Stock |
Michael G. Grey | Director | Sale of securities on an exchange or to another person at price $ 246.73 per share. | 14 Dec 2020 | 1,807 | 7,361 (0%) | 0% | 246.7 | 445,834 | Common Stock |
Michael G. Grey | Director | Sale of securities on an exchange or to another person at price $ 244.45 per share. | 14 Dec 2020 | 1,653 | 10,452 (0%) | 0% | 244.5 | 404,083 | Common Stock |
Michael G. Grey | Director | Sale of securities on an exchange or to another person at price $ 243.34 per share. | 14 Dec 2020 | 1,815 | 12,105 (0%) | 0% | 243.3 | 441,671 | Common Stock |
Michael G. Grey | Director | Sale of securities on an exchange or to another person at price $ 242.29 per share. | 14 Dec 2020 | 857 | 13,920 (0%) | 0% | 242.3 | 207,641 | Common Stock |
Michael G. Grey | Director | Sale of securities on an exchange or to another person at price $ 241.22 per share. | 14 Dec 2020 | 379 | 14,777 (0%) | 0% | 241.2 | 91,422 | Common Stock |
Michael G. Grey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.84 per share. | 14 Dec 2020 | 10,900 | 15,156 (0%) | 0% | 16.8 | 183,556 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 5,000 | 8,747 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 02 Nov 2020 | 5,000 | 44,437 (0%) | 0% | 5.5 | 27,500 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 4,284 | 21,757 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.99 per share. | 02 Nov 2020 | 1,595 | 39,437 (0%) | 0% | 25.0 | 39,859 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 1,595 | 40,825 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 02 Nov 2020 | 4,284 | 48,721 (0%) | 0% | 5.4 | 23,134 | Common Stock |
Vickie Reed | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 2,522 | 2,522 | - | - | Option Grant (Right to Buy) | |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 125.78 per share. | 11 Aug 2020 | 1,300 | 2,950 (0%) | 0% | 125.8 | 163,512 | Common Stock |
Bruce L.A. Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2020 | 2,250 | 6,750 | - | - | Non Qualified Stock Option (right to buy) | |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 131.16 per share. | 11 Aug 2020 | 100 | 2,000 (0%) | 0% | 131.2 | 13,116 | Common Stock |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 127.58 per share. | 11 Aug 2020 | 110 | 2,100 (0%) | 0% | 127.6 | 14,034 | Common Stock |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 126.71 per share. | 11 Aug 2020 | 740 | 2,210 (0%) | 0% | 126.7 | 93,767 | Common Stock |
Bruce L.A. Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.78 per share. | 11 Aug 2020 | 2,250 | 4,250 (0%) | 0% | 6.8 | 15,255 | Common Stock |
Henry J. Fuchs | Director | Sale of securities on an exchange or to another person at price $ 127.52 per share. | 10 Aug 2020 | 500 | 11,500 (0%) | 0% | 127.5 | 63,762 | Common Stock |
Henry J. Fuchs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2020 | 10,000 | 5,000 | - | - | Non Qualified Stock Option (right to buy) | |
Henry J. Fuchs | Director | Sale of securities on an exchange or to another person at price $ 133.07 per share. | 10 Aug 2020 | 500 | 2,000 (0%) | 0% | 133.1 | 66,536 | Common Stock |
Henry J. Fuchs | Director | Sale of securities on an exchange or to another person at price $ 132.34 per share. | 10 Aug 2020 | 5,800 | 2,500 (0%) | 0% | 132.3 | 767,568 | Common Stock |
Henry J. Fuchs | Director | Sale of securities on an exchange or to another person at price $ 131.08 per share. | 10 Aug 2020 | 1,300 | 8,300 (0%) | 0% | 131.1 | 170,408 | Common Stock |
Henry J. Fuchs | Director | Sale of securities on an exchange or to another person at price $ 129.80 per share. | 10 Aug 2020 | 1,000 | 9,600 (0%) | 0% | 129.8 | 129,803 | Common Stock |
Henry J. Fuchs | Director | Sale of securities on an exchange or to another person at price $ 128.56 per share. | 10 Aug 2020 | 900 | 10,600 (0%) | 0% | 128.6 | 115,707 | Common Stock |
Henry J. Fuchs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.54 per share. | 10 Aug 2020 | 10,000 | 12,000 (0%) | 0% | 20.5 | 205,400 | Common Stock |
Charles M. Baum | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Jul 2020 | 5,000 | 102,023 (0%) | 0% | 0 | Common Stock | |
James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 5,000 | 37,842 (0%) | 0% | 0 | Common Stock | |
Bruce L.A. Carter | Director | Sale of securities on an exchange or to another person at price $ 106.86 per share. | 18 May 2020 | 4,000 | 2,000 (0%) | 0% | 106.9 | 427,440 | Common Stock |
Bruce L.A. Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2020 | 4,000 | 9,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Bruce L.A. Carter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.78 per share. | 18 May 2020 | 4,000 | 6,000 (0%) | 0% | 6.8 | 27,120 | Common Stock |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.99 per share. | 11 May 2020 | 33,334 | 72,735 (0%) | 0% | 25.0 | 833,017 | Common Stock |
Isan Chen | EVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 105.00 per share. | 11 May 2020 | 33,334 | 39,401 (0%) | 0% | 105 | 3,500,070 | Common Stock |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2020 | 33,334 | 23,420 | - | - | Stock Options | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 27 Apr 2020 | 557 | 107,023 (0%) | 0% | 5.4 | 3,008 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2020 | 557 | 102,565 | - | - | Employee Stock Option (Right to Buy) | |
Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 93.00 per share. | 20 Apr 2020 | 15,000 | 2,000 (0%) | 0% | 93 | 1,395,000 | Common Stock |
Craig A. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.84 per share. | 20 Apr 2020 | 15,000 | 17,000 (0%) | 0% | 25.8 | 387,600 | Common Stock |
Craig A. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2020 | 15,000 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 89.59 per share. | 17 Apr 2020 | 10,526 | 135,940 (0%) | 0% | 89.6 | 943,058 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.49 per share. | 17 Apr 2020 | 40,000 | 146,466 (0%) | 0% | 8.5 | 339,600 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 91.63 per share. | 17 Apr 2020 | 4,290 | 106,466 (0%) | 0% | 91.6 | 393,092 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2020 | 40,000 | 127,204 | - | - | Employee Stock Option (Right to Buy) | |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 90.41 per share. | 17 Apr 2020 | 25,184 | 110,756 (0%) | 0% | 90.4 | 2,276,958 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2020 | 2,291 | 103,122 | - | - | Employee Stock Option (Right to Buy) | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 27 Mar 2020 | 2,291 | 106,466 (0%) | 0% | 5.4 | 12,371 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.99 per share. | 26 Mar 2020 | 2,580 | 27,364 (0%) | 0% | 25.0 | 64,474 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2020 | 888 | 12,879 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2020 | 2,084 | 26,041 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2020 | 1,256 | 13,747 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2020 | 2,580 | 42,420 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.51 per share. | 26 Mar 2020 | 1,250 | 32,842 (0%) | 0% | 21.5 | 26,888 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.41 per share. | 26 Mar 2020 | 888 | 31,592 (0%) | 0% | 17.4 | 15,460 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 26 Mar 2020 | 2,084 | 30,704 (0%) | 0% | 5.4 | 11,254 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 26 Mar 2020 | 1,256 | 28,620 (0%) | 0% | 5.5 | 6,908 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2020 | 1,250 | 13,750 | - | - | Employee Stock Option (Right to Buy) | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 28 Feb 2020 | 2,291 | 104,175 (0%) | 0% | 5.4 | 12,371 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2020 | 2,291 | 105,413 | - | - | Employee Stock Option (Right to Buy) | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 04 Feb 2020 | 2,291 | 99,488 (0%) | 0% | 5.4 | 12,371 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2020 | 2,291 | 107,704 | - | - | Employee Stock Option (Right to Buy) | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.99 per share. | 04 Feb 2020 | 2,396 | 101,884 (0%) | 0% | 25.0 | 59,876 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2020 | 2,396 | 111,652 | - | - | Employee Stock Option (Right to Buy) | |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.99 per share. | 29 Jan 2020 | 3,002 | 39,401 (0%) | 0% | 25.0 | 75,020 | Common Stock |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2020 | 3,002 | 56,754 | - | - | Stock Options | |
Daniel R. Faga | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2020 | 26,240 | 26,240 (0%) | 0% | 0 | Common Stock | |
Daniel R. Faga | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2020 | 64,970 | 64,970 | - | - | Employee Stock Option (Right to Buy) | |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2020 | 21,867 | 21,867 (0%) | 0% | 0 | Common Stock | |
Benjamin J. Hickey | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2020 | 32,485 | 32,485 | - | - | Employee Stock Option (Right to Buy) | |
Vickie Reed | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2020 | 5,500 | 5,500 | - | - | Employee Stock Option (Right to Buy) | |
Vickie Reed | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2020 | 2,750 | 8,250 (0%) | 0% | 0 | Common Stock | |
Bruce L.A. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 2,000 | 2,000 (0%) | 0% | 0 | Common Stock | |
Bruce L.A. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 4,000 | 4,000 | - | - | Non Qualified Stock Option (right to buy) | |
Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 6,000 | 6,000 | - | - | Non Qualified Stock Option (right to buy) | |
Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 3,000 | 3,000 (0%) | 0% | 0 | Common Stock | |
Henry J. Fuchs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 4,000 | 4,000 | - | - | Non Qualified Stock Option (right to buy) | |
Henry J. Fuchs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 2,000 | 2,000 (0%) | 0% | 0 | Common Stock | |
Michael G. Grey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 4,000 | 4,000 | - | - | Non Qualified Stock Option (right to buy) | |
Michael G. Grey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 2,000 | 4,256 (0%) | 0% | 0 | Common Stock | |
Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 2,000 | 2,000 (0%) | 0% | 0 | Common Stock | |
Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 4,000 | 4,000 | - | - | Non-Qualified Stock Option (Right to Buy) | |
Julie M. Cherrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 2,000 | 2,000 (0%) | 0% | 0 | Common Stock | |
Julie M. Cherrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 4,000 | 4,000 | - | - | Non Qualified Stock Option (right to buy) | |
Charles M. Baum | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 40,000 | 97,197 (0%) | 0% | 0 | Common Stock | |
Charles M. Baum | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 80,000 | 80,000 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 31,250 | 31,250 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 15,625 | 24,784 (0%) | 0% | 0 | Common Stock | |
Aaron I. Davis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 4,000 | 4,000 | - | - | Non Qualified Stock Option (right to buy) | |
Aaron I. Davis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 2,000 | 39,052 (0%) | 0% | 0 | Common Stock | |
Maria E Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 2,000 | 2,000 (0%) | 0% | 0 | Common Stock | |
Maria E Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2020 | 4,000 | 4,000 | - | - | Non Qualified Stock Option (right to buy) | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. | 24 Dec 2019 | 1 | 56,600 (0%) | 0% | 5 | 5 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Dec 2019 | 317 | 114,048 | - | - | Employee Stock Option (Right to Buy) | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Dec 2019 | 1 | 109,995 | - | - | Employee Stock Option (Right to Buy) | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.99 per share. | 24 Dec 2019 | 317 | 56,917 (0%) | 0% | 25.0 | 7,922 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 23 Dec 2019 | 4,167 | 13,326 (0%) | 0% | 5.4 | 22,502 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 23 Dec 2019 | 2,499 | 11,658 (0%) | 0% | 5.5 | 13,745 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 125.00 per share. | 23 Dec 2019 | 2,499 | 9,159 (0%) | 0% | 125 | 312,375 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2019 | 4,167 | 28,125 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2019 | 2,499 | 15,003 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 125.00 per share. | 23 Dec 2019 | 4,167 | 9,159 (0%) | 0% | 125 | 520,875 | Common Stock |
Charles M. Baum | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2019 | 10,000 | 56,599 (0%) | 0% | 0 | Common Stock | |
Bruce L.A. Carter | None | Sale of securities on an exchange or to another person at price $ 94.74 per share. | 20 Nov 2019 | 3,000 | 0 (0%) | 0% | 94.7 | 284,220 | Common Stock |
Bruce L.A. Carter | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2019 | 3,000 | 13,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Bruce L.A. Carter | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.78 per share. | 20 Nov 2019 | 3,000 | 3,000 (0%) | 0% | 6.8 | 20,340 | Common Stock |
Michael G. Grey | None | Sale of securities on an exchange or to another person at price $ 102.44 per share. | 12 Nov 2019 | 3,042 | 2,256 (0%) | 0% | 102.4 | 311,622 | Common Stock |
Michael G. Grey | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2019 | 3,500 | 10,900 | - | - | Non-Qualified Stock Option (Right to Buy) | |
Michael G. Grey | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.84 per share. | 12 Nov 2019 | 3,500 | 5,298 (0%) | 0% | 16.8 | 58,940 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.99 per share. | 22 Aug 2019 | 556 | 66,599 (0%) | 0% | 25.0 | 13,894 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2019 | 556 | 114,365 | - | - | Stock Option (Right to buy) | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2019 | 2 | 109,996 | - | - | Stock Option (Right to buy) | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2019 | 51,810 | 0 | - | - | Stock Option (Right to buy) | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 22 Aug 2019 | 2 | 66,043 (0%) | 0% | 5.5 | 11 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 91.12 per share. | 22 Aug 2019 | 1,736 | 66,041 (0%) | 0% | 91.1 | 158,177 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 89.24 per share. | 22 Aug 2019 | 1,622 | 67,777 (0%) | 0% | 89.2 | 144,753 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 88.24 per share. | 22 Aug 2019 | 4,544 | 69,399 (0%) | 0% | 88.2 | 400,967 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 86.58 per share. | 22 Aug 2019 | 3,619 | 73,943 (0%) | 0% | 86.6 | 313,326 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 85.89 per share. | 22 Aug 2019 | 28,446 | 77,562 (0%) | 0% | 85.9 | 2,443,093 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 85.03 per share. | 22 Aug 2019 | 11,843 | 106,008 (0%) | 0% | 85.0 | 1,006,996 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.50 per share. | 22 Aug 2019 | 51,810 | 117,851 (0%) | 0% | 8.5 | 440,385 | Common Stock |
Bruce L.A. Carter | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.78 per share. | 21 Aug 2019 | 3,000 | 3,000 (0%) | 0% | 6.8 | 20,340 | Common Stock |
Bruce L.A. Carter | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2019 | 3,000 | 16,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Bruce L.A. Carter | None | Sale of securities on an exchange or to another person at price $ 89.24 per share. | 21 Aug 2019 | 3,000 | 0 (0%) | 0% | 89.2 | 267,720 | Common Stock |
Michael G. Grey | None | Sale of securities on an exchange or to another person at price $ 93.18 per share. | 12 Aug 2019 | 650 | 2,058 (0%) | 0% | 93.2 | 60,569 | Common Stock |
Michael G. Grey | None | Sale of securities on an exchange or to another person at price $ 92.34 per share. | 12 Aug 2019 | 1,100 | 2,708 (0%) | 0% | 92.3 | 101,575 | Common Stock |
Michael G. Grey | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.84 per share. | 12 Aug 2019 | 3,500 | 4,840 (0%) | 0% | 16.8 | 58,940 | Common Stock |
Michael G. Grey | None | Sale of securities on an exchange or to another person at price $ 91.20 per share. | 12 Aug 2019 | 1,032 | 3,808 (0%) | 0% | 91.2 | 94,119 | Common Stock |
Michael G. Grey | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2019 | 3,500 | 14,400 | - | - | Non-Qualified Stock Option (Right to Buy) | |
Michael G. Grey | None | Sale of securities on an exchange or to another person at price $ 93.98 per share. | 12 Aug 2019 | 260 | 1,798 (0%) | 0% | 94.0 | 24,434 | Common Stock |
Julie M. Cherrington | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2019 | 25,000 | 25,000 | - | - | Non Qualified Stock Option (right to buy) | |
Bruce L.A. Carter | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2019 | 3,000 | 19,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Bruce L.A. Carter | None | Sale of securities on an exchange or to another person at price $ 75.20 per share. | 22 May 2019 | 3,000 | 0 (0%) | 0% | 75.2 | 225,597 | Common Stock |
Bruce L.A. Carter | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.78 per share. | 22 May 2019 | 3,000 | 3,000 (0%) | 0% | 6.8 | 20,340 | Common Stock |
Jamie A. Donadio | Sr. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 16 May 2019 | 7,500 | 7,721 (0%) | 0% | 5.5 | 41,250 | Common Stock |
Jamie A. Donadio | Sr. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2019 | 7,500 | 13,125 | - | - | Employee Stock Option (Right to Buy) | |
Jamie A. Donadio | Sr. VP, CFO | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 16 May 2019 | 7,500 | 221 (0%) | 0% | 75 | 562,500 | Common Stock |
Michael G. Grey | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.84 per share. | 13 May 2019 | 7,100 | 7,100 (0%) | 0% | 16.8 | 119,564 | Common Stock |
Michael G. Grey | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2019 | 7,100 | 17,900 | - | - | Non-Qualified Stock Option (Right to Buy) | |
Michael G. Grey | None | Sale of securities on an exchange or to another person at price $ 66.08 per share. | 13 May 2019 | 300 | 1,340 (0%) | 0% | 66.1 | 19,825 | Common Stock |
Michael G. Grey | None | Sale of securities on an exchange or to another person at price $ 65.26 per share. | 13 May 2019 | 5,460 | 1,640 (0%) | 0% | 65.3 | 356,314 | Common Stock |
Neil A. Reisman | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 04 Apr 2019 | 54,210 | 87,607 (0%) | 0% | 0 | Common Stock | |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 75.77 per share. | 25 Feb 2019 | 18,235 | 73,894 (0%) | 0% | 75.8 | 1,381,642 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.50 per share. | 25 Feb 2019 | 51,810 | 117,851 (0%) | 0% | 8.5 | 440,385 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2019 | 51,810 | 51,810 | - | - | Common Stock | |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 79.09 per share. | 25 Feb 2019 | 100 | 66,041 (0%) | 0% | 79.1 | 7,909 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 77.96 per share. | 25 Feb 2019 | 2,066 | 66,141 (0%) | 0% | 78.0 | 161,064 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 76.75 per share. | 25 Feb 2019 | 5,687 | 68,207 (0%) | 0% | 76.8 | 436,503 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 75.17 per share. | 25 Feb 2019 | 25,722 | 92,129 (0%) | 0% | 75.2 | 1,933,554 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 21 Feb 2019 | 2 | 62,499 (0%) | 0% | 5.5 | 11 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.99 per share. | 21 Feb 2019 | 79 | 62,497 (0%) | 0% | 25.0 | 1,974 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.51 per share. | 21 Feb 2019 | 3,542 | 66,041 (0%) | 0% | 21.5 | 76,188 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2019 | 79 | 114,921 | - | - | Stock Option (Right to Buy) | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2019 | 2 | 109,998 | - | - | Stock Option (Right to Buy) | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2019 | 3,542 | 81,458 | - | - | Stock Option (Right to Buy) | |
Bruce L.A. Carter | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.78 per share. | 20 Feb 2019 | 3,000 | 3,000 (0%) | 0% | 6.8 | 20,340 | Common Stock |
Bruce L.A. Carter | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2019 | 3,000 | 22,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Bruce L.A. Carter | None | Sale of securities on an exchange or to another person at price $ 74.44 per share. | 20 Feb 2019 | 1,100 | 0 (0%) | 0% | 74.4 | 81,882 | Common Stock |
Bruce L.A. Carter | None | Sale of securities on an exchange or to another person at price $ 73.79 per share. | 20 Feb 2019 | 1,000 | 1,100 (0%) | 0% | 73.8 | 73,789 | Common Stock |
Bruce L.A. Carter | None | Sale of securities on an exchange or to another person at price $ 72.50 per share. | 20 Feb 2019 | 900 | 2,100 (0%) | 0% | 72.5 | 65,250 | Common Stock |
Faheem Hasnain | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 47,000 | 47,000 | - | - | Non-Qualified Stock Option (Right to Buy) | |
Jamie A. Donadio | Sr. VP, CFO | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 15 Feb 2019 | 7,500 | 221 (0%) | 0% | 75.0 | 562,502 | Common Stock |
Jamie A. Donadio | Sr. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 7,500 | 30,000 | - | - | Employee Stock Option (Right to Buy) | |
Jamie A. Donadio | Sr. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 15 Feb 2019 | 7,500 | 7,721 (0%) | 0% | 5.4 | 40,500 | Common Stock |
Christopher C. Lemasters | EVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 71.65 per share. | 14 Feb 2019 | 41,438 | 18,562 (0%) | 0% | 71.6 | 2,968,966 | Common Stock |
Christopher C. Lemasters | EVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2019 | 60,000 | 60,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Christopher C. Lemasters | EVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 72.06 per share. | 14 Feb 2019 | 18,562 | 0 (0%) | 0% | 72.1 | 1,337,489 | Common Stock |
Christopher C. Lemasters | EVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.45 per share. | 14 Feb 2019 | 60,000 | 60,000 (0%) | 0% | 6.5 | 387,000 | Common Stock |
Craig A. Johnson | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.65 per share. | 29 Jan 2019 | 10,000 | 17,000 (0%) | 0% | 3.7 | 36,500 | Common Stock |
Craig A. Johnson | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2019 | 10,000 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | |
Craig A. Johnson | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2019 | 7,000 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | |
Craig A. Johnson | None | Sale of securities on an exchange or to another person at price $ 61.80 per share. | 29 Jan 2019 | 8,525 | 0 (0%) | 0% | 61.8 | 526,831 | Common Stock |
Craig A. Johnson | None | Sale of securities on an exchange or to another person at price $ 61.11 per share. | 29 Jan 2019 | 8,475 | 8,525 (0%) | 0% | 61.1 | 517,941 | Common Stock |
Craig A. Johnson | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.79 per share. | 29 Jan 2019 | 7,000 | 7,000 (0%) | 0% | 15.8 | 110,530 | Common Stock |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.51 per share. | 23 Jan 2019 | 625 | 35,835 (0%) | 0% | 21.5 | 13,444 | Common Stock |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2019 | 1 | 49,997 | - | - | Employee Stock Option (Right to Buy) | |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2019 | 625 | 25,283 | - | - | Employee Stock Option (Right to Buy) | |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2019 | 244 | 59,756 | - | - | Stock Options | |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. | 23 Jan 2019 | 1 | 35,836 (0%) | 0% | 5 | 5 | Common Stock |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.99 per share. | 23 Jan 2019 | 244 | 35,210 (0%) | 0% | 25.0 | 6,098 | Common Stock |
Bruce L.A. Carter | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2019 | 11,000 | 11,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Henry J. Fuchs | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2019 | 11,000 | 11,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Michael G. Grey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2019 | 11,000 | 11,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Craig A. Johnson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2019 | 11,000 | 11,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Rodney W. Lappe | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2019 | 11,000 | 11,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Charles M. Baum | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2019 | 170,000 | 170,000 | - | - | Option Grant (Right to Buy) | |
Jamie A. Donadio | Sr. VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2019 | 60,000 | 60,000 | - | - | Option Grant (Right to Buy) | |
Isan Chen | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2019 | 60,000 | 60,000 | - | - | Option Grant (Right to Buy) | |
James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2019 | 60,000 | 60,000 | - | - | Option Grant (Right to Buy) | |
Christopher C. Lemasters | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2019 | 60,000 | 60,000 | - | - | Option Grant (Right to Buy) | |
Aaron I. Davis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2019 | 11,000 | 11,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Maria E Martinez | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2019 | 11,000 | 11,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Neil A. Reisman | Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.20 per share. | 11 Jan 2019 | 50 | 33,397 (0%) | 0% | 60.2 | 3,010 | Common Stock |
Neil A. Reisman | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2019 | 15,972 | 0 | - | - | Employee Stock Option (right to buy) | |
Neil A. Reisman | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2019 | 10,000 | 0 | - | - | Employee Stock Option (right to buy) | |
Neil A. Reisman | Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.50 per share. | 11 Jan 2019 | 5,656 | 33,447 (0%) | 0% | 59.5 | 336,532 | Common Stock |
Neil A. Reisman | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.05 per share. | 11 Jan 2019 | 15,972 | 39,103 (0%) | 0% | 4.1 | 64,687 | Common Stock |
Neil A. Reisman | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.00 per share. | 11 Jan 2019 | 10,000 | 23,131 (0%) | 0% | 27 | 270,000 | Common Stock |
Aaron I. Davis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 53.40 per share. | 07 Jan 2019 | 5,000 | 37,052 (0%) | 0% | 53.4 | 267,000 | Common Stock |
Aaron I. Davis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.29 per share. | 07 Jan 2019 | 8,357 | 62,052 (0%) | 0% | 46.3 | 386,846 | Common Stock |
Aaron I. Davis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 47.48 per share. | 07 Jan 2019 | 15,000 | 47,052 (0%) | 0% | 47.5 | 712,200 | Common Stock |
Aaron I. Davis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 52.20 per share. | 07 Jan 2019 | 5,000 | 42,052 (0%) | 0% | 52.2 | 261,000 | Common Stock |
Aaron I. Davis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.47 per share. | 07 Jan 2019 | 16,643 | 70,409 (0%) | 0% | 45.5 | 756,757 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.41 per share. | 26 Dec 2018 | 5,169 | 8,789 (0%) | 0% | 17.4 | 89,992 | Common Stock |
James Christensen | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Dec 2018 | 5,169 | 13,767 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2018 | 30,000 | 30,000 | - | - | Option Grant (Right to Buy) | |
Aaron I. Davis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2018 | 25,000 | 25,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Maria E Martinez | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2018 | 25,000 | 25,000 | - | - | Non Qualified Stock Option (right to buy) | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.41 per share. | 23 Aug 2018 | 11,486 | 62,418 (0%) | 0% | 17.4 | 199,971 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 58.40 per share. | 23 Aug 2018 | 1,862 | 50,932 (0%) | 0% | 58.4 | 108,734 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 57.86 per share. | 23 Aug 2018 | 32,514 | 52,794 (0%) | 0% | 57.9 | 1,881,325 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 56.88 per share. | 23 Aug 2018 | 17,434 | 85,308 (0%) | 0% | 56.9 | 991,730 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.50 per share. | 23 Aug 2018 | 51,810 | 102,742 (0%) | 0% | 8.5 | 440,385 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2018 | 51,810 | 103,620 | - | - | Common Stock | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2018 | 11,486 | 138,514 | - | - | Common Stock | |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.41 per share. | 16 Jul 2018 | 275 | 32,111 (0%) | 0% | 17.4 | 4,788 | Common Stock |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2018 | 1,592 | 25,908 | - | - | Employee Stock Option (Right to Buy) | |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2018 | 275 | 5,913 | - | - | Employee Stock Option (Right to Buy) | |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.51 per share. | 16 Jul 2018 | 1,592 | 34,582 (0%) | 0% | 21.5 | 34,244 | Common Stock |
James Christensen | SVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 49.27 per share. | 26 Jun 2018 | 1,150 | 3,394 (0%) | 0% | 49.3 | 56,658 | Common Stock |
James Christensen | SVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 48.62 per share. | 26 Jun 2018 | 4,058 | 4,027 (0%) | 0% | 48.6 | 197,307 | Common Stock |
James Christensen | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 26 Jun 2018 | 5,208 | 8,085 (0%) | 0% | 5.4 | 28,123 | Common Stock |
James Christensen | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2018 | 5,208 | 32,292 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2018 | 4,999 | 17,502 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | SVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 51.31 per share. | 26 Jun 2018 | 29 | 3,394 (0%) | 0% | 51.3 | 1,488 | Common Stock |
James Christensen | SVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 50.15 per share. | 26 Jun 2018 | 736 | 3,423 (0%) | 0% | 50.1 | 36,910 | Common Stock |
James Christensen | SVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 49.43 per share. | 26 Jun 2018 | 4,234 | 4,159 (0%) | 0% | 49.4 | 209,266 | Common Stock |
James Christensen | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 26 Jun 2018 | 4,999 | 8,393 (0%) | 0% | 5.5 | 27,495 | Common Stock |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.51 per share. | 25 Apr 2018 | 2,500 | 31,836 (0%) | 0% | 21.5 | 53,775 | Common Stock |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2018 | 2 | 49,998 | - | - | Employee Stock Option (Right to Buy) | |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2018 | 10,124 | 96,668 | - | - | Employee Stock Option (Right to Buy) | |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2018 | 412 | 6,188 | - | - | Employee Stock Option (Right to Buy) | |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2018 | 2,500 | 27,500 | - | - | Employee Stock Option (Right to Buy) | |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.41 per share. | 25 Apr 2018 | 412 | 29,336 (0%) | 0% | 17.4 | 7,173 | Common Stock |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.79 per share. | 25 Apr 2018 | 10,124 | 28,924 (0%) | 0% | 15.8 | 159,858 | Common Stock |
Isan Chen | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 25 Apr 2018 | 2 | 18,800 (0%) | 0% | 5.5 | 11 | Common Stock |
Jamie A. Donadio | Sr. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.41 per share. | 09 Mar 2018 | 12,100 | 12,100 (0%) | 0% | 17.4 | 210,661 | Common Stock |
Jamie A. Donadio | Sr. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2018 | 12,100 | 1,100 | - | - | Employee Stock Option (Right to Buy) | |
Jamie A. Donadio | Sr. VP, CFO | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 09 Mar 2018 | 12,100 | 0 (0%) | 0% | 35 | 423,500 | Common Stock |
James Christensen | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2018 | 7,000 | 18,936 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2018 | 7,500 | 15,000 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2018 | 7,500 | 45,000 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.99 per share. | 09 Mar 2018 | 7,500 | 24,877 (0%) | 0% | 25.0 | 187,425 | Common Stock |
James Christensen | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.41 per share. | 09 Mar 2018 | 7,000 | 9,877 (0%) | 0% | 17.4 | 121,870 | Common Stock |
James Christensen | SVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 33.00 per share. | 09 Mar 2018 | 22,000 | 2,877 (0%) | 0% | 33.0 | 726,040 | Common Stock |
James Christensen | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.51 per share. | 09 Mar 2018 | 7,500 | 17,377 (0%) | 0% | 21.5 | 161,325 | Common Stock |
Jamie A. Donadio | Sr. VP, CFO | Sale of securities on an exchange or to another person at price $ 26.78 per share. | 01 Mar 2018 | 25,600 | 26,275 (0%) | 0% | 26.8 | 685,514 | Common Stock |
Jamie A. Donadio | Sr. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2018 | 12,500 | 37,500 | - | - | Employee Stock Option (Right to Buy) | |
Jamie A. Donadio | Sr. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2018 | 9,375 | 20,625 | - | - | Employee Stock Option (Right to Buy) | |
Jamie A. Donadio | Sr. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 01 Mar 2018 | 12,500 | 21,875 (0%) | 0% | 5.4 | 67,500 | Common Stock |
Jamie A. Donadio | Sr. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.30 per share. | 01 Mar 2018 | 30,000 | 51,875 (0%) | 0% | 7.3 | 219,000 | Common Stock |
Jamie A. Donadio | Sr. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 01 Mar 2018 | 9,375 | 9,375 (0%) | 0% | 5.5 | 51,563 | Common Stock |
Jamie A. Donadio | Sr. VP, CFO | Sale of securities on an exchange or to another person at price $ 27.45 per share. | 01 Mar 2018 | 25,775 | 500 (0%) | 0% | 27.5 | 707,591 | Common Stock |
Jamie A. Donadio | Sr. VP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2018 | 30,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Jamie A. Donadio | Sr. VP, CFO | Sale of securities on an exchange or to another person at price $ 28.08 per share. | 01 Mar 2018 | 500 | 0 (0%) | 0% | 28.1 | 14,040 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 27.89 per share. | 23 Feb 2018 | 40,748 | 59,618 (0%) | 0% | 27.9 | 1,136,551 | Common Stock |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2018 | 51,810 | 155,430 | - | - | Common Stock | |
Charles M. Baum | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.50 per share. | 23 Feb 2018 | 51,810 | 100,366 (0%) | 0% | 8.5 | 440,385 | Common Stock |
Charles M. Baum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 28.56 per share. | 23 Feb 2018 | 11,062 | 50,932 (0%) | 0% | 28.6 | 315,906 | Common Stock |
James Christensen | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2018 | 8,000 | 25,936 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2018 | 7,500 | 52,500 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2018 | 7,500 | 22,500 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.41 per share. | 06 Feb 2018 | 8,000 | 10,877 (0%) | 0% | 17.4 | 139,280 | Common Stock |
James Christensen | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.51 per share. | 06 Feb 2018 | 7,500 | 25,877 (0%) | 0% | 21.5 | 161,325 | Common Stock |
James Christensen | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.99 per share. | 06 Feb 2018 | 7,500 | 18,377 (0%) | 0% | 25.0 | 187,425 | Common Stock |
James Christensen | SVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 06 Feb 2018 | 23,000 | 2,877 (0%) | 0% | 30 | 690,000 | Common Stock |
James Christensen | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2018 | 12,500 | 37,500 | - | - | Employee Stock Option (Right to Buy) | |
James Christensen | SVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 26.11 per share. | 26 Jan 2018 | 12,500 | 2,877 (0%) | 0% | 26.1 | 326,423 | Common Stock |
James Christensen | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 26 Jan 2018 | 12,500 | 15,377 (0%) | 0% | 5.4 | 67,500 | Common Stock |
Bruce L.A. Carter | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2018 | 10,000 | 10,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Henry J. Fuchs | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2018 | 10,000 | 10,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Michael G. Grey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2018 | 10,000 | 10,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Craig A. Johnson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2018 | 10,000 | 10,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Neil A. Reisman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2018 | 10,000 | 10,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Rodney W. Lappe | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2018 | 15,000 | 15,000 | - | - | Non-Qualified Stock Option (right to buy) |